TuHURA Biosciences (HURA) Earnings Date & Reports

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HURA is expected to report earnings to fall 19.23% to -10 cents per share on August 14

TuHURA Biosciences HURA Stock Earnings Reports

Q2'26

Est.

$-0.10

Q1'26

Missed

by $0.04

Q4'25

Beat

by $0.02

Q2'25

Missed

by $0.04

Q1'25

Beat

by $0.02

The last earnings report on May 12 showed earnings per share of -12 cents, missing the estimate of -9 cents. With 368.58K shares outstanding, the current market capitalization sits at 172.58M.

View a ticker or compare two or three

Compare

HURA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for HURA